A clinical laboratory–developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia

Leukemia stem cells (LSCs) are linked to relapse in acute myeloid leukemia (AML). The LSC17 gene expression score robustly captures LSC stemness properties in AML and can be used to predict survival outcomes and response to therapy, enabling risk-adapted, upfront treatment approaches. The LSC17 scor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Stanley W. K., Murphy, Tracy, King, Ian, Zhang, Tong, Mah, Michelle, Lu, Zhibin, Stickle, Natalie, Ibrahimova, Narmin, Arruda, Andrea, Mitchell, Amanda, Mai, Ming, He, Rong, Madala, Bindu Swapna, Viswanatha, David S., Dick, John E., Chan, Steven, Virtanen, Carl, Minden, Mark D., Mercer, Timothy, Stockley, Tracy, Wang, Jean C. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Myeloid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945314/
https://www.ncbi.nlm.nih.gov/pubmed/34872104
http://dx.doi.org/10.1182/bloodadvances.2021005741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945314/
https://www.ncbi.nlm.nih.gov/pubmed/34872104
http://dx.doi.org/10.1182/bloodadvances.2021005741

Ejemplares similares